A unique model
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
-
![]()
News Three IRIC researchers receive substantial support from the Canada Foundation for Innovation
On August 18, 2020, the Canada Foundation for Innovation (CFI) announced the selected research projects that will benefit from its financial support. This substantial support allows researchers to acquire highly specialized avant-garde equipment and infrastructure, and to recruit and retain internationally renowned scientists.
-
![]()
News Genome-wide screens reveal that resveratrol induces replicative stress in human cells
Resveratrol (RSV) is a natural compound found in many plants, including the skin of grapes (and in wine), blueberries, raspberries, mulberries and peanuts. It has attracted considerable research attention due to its reported beneficial properties in experimental models such as yeasts, nematode worms, fruit flies and mice, including lifespan extension under certain conditions. A causal role of RSV in human health has not yet been established.
-
![]()
News 2020 IRIC Next Generation Awards Competition: a successful edition in the midst of a pandemic
As always, IRIC is actively involved in training the next generation of scientists. That’s why, since 2011, the Institute has made it possible for Canadian undergraduate students to carry out a summer internship in one of its laboratories as part of the IRIC Next Generation Awards Competition. This summer, however, the unique health context and teleworking have upended the training of these research interns.
-
![]()
News The project carried out by Sylvie Mader and her team receives the LeadAction|Breast Cancer du Sein grant
While the pandemic has highlighted the importance of supporting scientific research, IRICoR and the Quebec Breast Cancer Foundation (QBCF) have joined forces through their joint LeadAction|Breast Cancer Competition to accelerate breast cancer research work and develop additional therapeutic options for those affected by this cancer.
-
![]()
News Céline Laumont, IRIC Ph.D. graduate, is awarded a Banting Postdoctoral Fellowship
Following the 2019-2020 Banting Postdoctoral Fellowships Competition, Céline Laumont, IRIC Ph.D. graduate, received a prestigious award for her project “B cell-mediated immunity in high-grade serous ovarian cancer”.
-
![]()
News IRIC is pleased to mark more than 10 years of partnership with Pomerleau and acknowledges its outstanding support
On June 1, 2020, Pomerleau, one of Canada’s most innovative construction leaders and a pioneer in sustainable buildings and renewable energy, launched its “Love is an essential service” initiative to support efforts to fight COVID-19. As part of that initiative, philanthropic donations were distributed to 14 community organizations across the country working in three major sectors of activity related to the current health crisis, namely: health, research and food. As a result, IRIC has been allocated a substantial amount, deposited into the Institute’s Emergency Fund, to allow its investigators to continue their research activities in a bold and unique way, despite the constraints stemming from the pandemic.
-
![]()
News Race for the discovery of COVID-19 medications: A multidisciplinary project takes shape!
Génome Québec, in partnership with IRIC, Université de Montréal, Mila – Quebec Artificial Intelligence Institute and McMaster University, is proud to announce funding for a new research project intended to accelerate the discovery of antiviral COVID-19 medications. Spearheaded by professors Michael Tyers (IRIC / Université de Montréal), Yoshua Bengio (Mila / Université de Montréal) and Anne Marinier (IRIC / Université de Montréal), the $1 million project was launched in fast-track mode on June 1, 2020.
-
![]()
News IRIC broadens its ranks by recruiting David Knapp and Geneviève Deblois as new Principal Investigators
The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that David Knapp and Geneviève Deblois have been recruited as new Principal Investigators. They are in charge, respectively, of the Cellular Engineering Research Unit and the Metabolic and Epigenetic Alterations in Cancer Research Unit.
Upcoming events
-
septembre 14—novembre 30, 2020 Distinguished scientist lecture series
IRIC presents the thirtieth edition of its Distinguished Scientist Lecture Series, with a full nine part program. Join us on Mondays at 11:30 am, to learn about the latest findings in cancer research with leading biomedical investigators from Canada, USA and Europe.
-
Upcoming septembre 30, 2020 A vaccine against acute myeloid leukemia?
On September 30, Dr. Claude Perreault and his collaborators, Krystel Vincent and Marie-Pierre Hardy, will present a conference titled “Un vaccin contre la leucémie myéloïde aiguë?″ (A vaccine against acute myeloid leukemia?) organized by the Leukemia & Lymphoma Society of Canada (Quebec Region).
-
Upcoming février 4, 2021
Latest publications
See all publications-
septembre 1, 2020 Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.
Deblois G, Tonekaboni SAM, Grillo G, Martinez C, Kao YI, Tai F, Ettayebi I, Fortier AM, Savage P, Fedor AN, Liu X, Guilhamon P, Lima-Fernandes E, Murison A, Kuasne H, Ba-Alawi W, Cescon DW, Arrowsmith CH, De Carvalho DD, Haibe-Kains B, Locasale JW, Park M, Lupien M
Cancer Discov 2020-09-01 ;10( 9 ):1312-1329. - See all publications